Viking Therapeutics to Report Q2 Earnings: What's in Store for the Stock?Zacks Investment Research • 07/17/26
Viking Therapeutics, Inc. (VKTX) Stock Falls Amid Market Uptick: What Investors Need to KnowZacks Investment Research • 07/10/26
Viking Therapeutics (VKTX) Price Forecast: Bottoming Pattern Signals Growing StrengthFXEmpire • 07/09/26
Why Viking Therapeutics, Inc. (VKTX) Dipped More Than Broader Market TodayZacks Investment Research • 07/08/26
CRISPR Therapeutics vs. Viking Therapeutics: Is a Gene-Editing or Weight Loss Focused Stock Is a Better Buy in 2026?The Motley Fool • 07/07/26
CRISPR Therapeutics vs. Viking Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?The Motley Fool • 07/06/26
Is Viking Therapeutics Stock Going to $50? Here's What the Bulls and Bears Are SayingThe Motley Fool • 07/04/26
Novo Nordisk vs. Viking: Which Obesity Drug Stock Is the Better Buy?Zacks Investment Research • 06/29/26
Dyne Therapeutics vs. Viking Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?The Motley Fool • 06/26/26
VKTX Stock Jumps on Phase I Study Initiation for New Obesity DrugZacks Investment Research • 06/25/26
Viking Therapeutics Announces Initiation of Phase 1 Study to Evaluate Novel Amylin Receptor Agonist VK3019 in Healthy AdultsPRNewsWire • 06/24/26